Ladenburg Thalmann Assumes Corvus Pharmaceuticals (CRVS) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| (NASDAQ: CRVS) | Delayed: 9.70 -0.33 (3.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.03 | 52 Week High | $17.77 | |||
| Open | $10.10 | 52 Week Low | $9.63 | |||
| Day High | $10.21 | P/E | N/A | |||
| Day Low | $9.58 | EPS | $0.00 | |||
| Volume | 614,511 | |||||
